for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

财经

Bristol-Myers buys Celgene for $74 billion

Bristol-Myers Squibb is buying Celgene for about $74 billion, creating a major pharma company with several blockbuster cancer drugs as competition in the immunotherapy sector heats up. Fred Katayama reports.

财经

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up